Skip to content

Inspiratory Muscle Training in Patients With Autonomic Neuropathic

Inspiratory Muscle Training in Patients With Autonomic Neuropathic: a Randomized Trial

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00752440
Enrollment
24
Registered
2008-09-15
Start date
2006-08-31
Completion date
2009-07-31
Last updated
2008-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Diabetic Autonomic Neuropathy

Keywords

Diabetes Mellitus, Autonomic Neuropathy, Inspiratory Muscle training

Brief summary

This study describes a controlled randomized clinical trial to evaluate the effect of inspiratory muscle training in patients with diabetic autonomic neuropathy.

Detailed description

The diabetic autonomic neuropathy (NAD) is a common complication of diabetes mellitus (DM), both of the type 1 diabetes mellitus (DM1) as of the type 2 diabetes mellitus (DM2). The results of this study, would help to reveal the degree of commitment generated by NAD in respiratory muscle strength, can also enable the development of a new therapeutic approach, such non-pharmacological (respiratory muscle training), with a view to improve the respiratory muscle strength and alleviate the autonomic dysfunction in these patients.

Interventions

OTHERInspiratory muscle training (IMT)

IMT (30 min 7 times per week, for 8 weeks)

Sponsors

Instituto de Cardiologia do Rio Grande do Sul
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
35 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Diabetic autonomic neuropathy * Age between 36 and * 70 years old and signed in informed consent form

Exclusion criteria

* Presence of congestive heart failure * Chronic obstructive pulmonary disease (FEV1 \< 70% and/or FEV1%\< 80 * Class II or III obesity (body mass index \> 35)

Design outcomes

Primary

MeasureTime frame
Inspiratory muscle strengtheight

Secondary

MeasureTime frame
Variability of heart rateeight

Countries

Brazil

Contacts

Primary ContactBeatriz D Schaan, MD, ScD
beatrizschann@gmail.com555132303600

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026